Micropos Medical AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 0.291 million compared to SEK 0.222 million a year ago. Revenue was SEK 0.482 million compared to SEK 0.457 million a year ago. Net loss was SEK 7.46 million compared to SEK 5.24 million a year ago. Basic loss per share from continuing operations was SEK 0.05 compared to SEK 0.04 a year ago.
For the six months, sales was SEK 0.969 million compared to SEK 0.602 million a year ago. Revenue was SEK 2.49 million compared to SEK 0.938 million a year ago. Net loss was SEK 12.5 million compared to SEK 9.56 million a year ago. Basic loss per share from continuing operations was SEK 0.05 compared to SEK 0.08 a year ago.